Autologous Stem Cell Based Therapies Market Report

Global and Region Autologous Stem Cell Based Therapies Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：220
  • REPORT CODE：GMM889849
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Autologous Stem Cell Based Therapies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Autologous Stem Cell Based Therapiesmarket, defines the market attractiveness level of Autologous Stem Cell Based Therapies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Autologous Stem Cell Based Therapies industry, describes the types of Autologous Stem Cell Based Therapies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Autologous Stem Cell Based Therapies market and the development prospects and opportunities of Autologous Stem Cell Based Therapies industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Autologous Stem Cell Based Therapies market in Chapter 13.

    By Player:

    • Pluristem Therapeutics Inc

    • US STEM CELL, INC

    • Brainstorm Cell Therapeutics

    • Tigenix

    • Mesoblast

    • Regeneus

    • Med cell Europe

    By Type:

    • Embryonic Stem Cell

    • Resident Cardiac Stem Cells

    • Umbilical Cord Blood Stem Cells

    By End-User:

    • Neurodegenerative Disorders

    • Autoimmune Diseases

    • Cardiovascular Diseases

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Autologous Stem Cell Based Therapies Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Autologous Stem Cell Based Therapies Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Autologous Stem Cell Based Therapies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Autologous Stem Cell Based Therapies Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Autologous Stem Cell Based Therapies Market Analysis and Outlook to 2022

    • 7.1 Global Autologous Stem Cell Based Therapies Consumption (2017-2022)

    • 7.2 United States Autologous Stem Cell Based Therapies Consumption (2017-2022)

    • 7.3 Europe Autologous Stem Cell Based Therapies Consumption (2017-2022)

    • 7.4 China Autologous Stem Cell Based Therapies Consumption (2017-2022)

    • 7.5 Japan Autologous Stem Cell Based Therapies Consumption (2017-2022)

    • 7.6 India Autologous Stem Cell Based Therapies Consumption (2017-2022)

    • 7.7 South Korea Autologous Stem Cell Based Therapies Consumption (2017-2022)

    8 Region and Country-wise Autologous Stem Cell Based Therapies Market Analysis and Outlook to 2028

    • 8.1 Global Autologous Stem Cell Based Therapies Consumption Forecast (2022-2028)

    • 8.2 United States Autologous Stem Cell Based Therapies Consumption Forecast (2022-2028)

    • 8.3 Europe Autologous Stem Cell Based Therapies Consumption Forecast (2022-2028)

    • 8.4 China Autologous Stem Cell Based Therapies Consumption Forecast (2022-2028)

    • 8.5 Japan Autologous Stem Cell Based Therapies Consumption Forecast (2022-2028)

    • 8.6 India Autologous Stem Cell Based Therapies Consumption Forecast (2022-2028)

    • 8.7 South Korea Autologous Stem Cell Based Therapies Consumption Forecast (2022-2028)

    9 Global Autologous Stem Cell Based Therapies Market Outlook by Types and Applications to 2022

    • 9.1 Global Autologous Stem Cell Based Therapies Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Embryonic Stem Cell Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Resident Cardiac Stem Cells Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Umbilical Cord Blood Stem Cells Consumption and Growth Rate (2017-2022)

    • 9.2 Global Autologous Stem Cell Based Therapies Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Neurodegenerative Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

    10 Global Autologous Stem Cell Based Therapies Market Outlook by Types and Applications to 2028

    • 10.1 Global Autologous Stem Cell Based Therapies Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Embryonic Stem Cell Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Resident Cardiac Stem Cells Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Umbilical Cord Blood Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Autologous Stem Cell Based Therapies Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Neurodegenerative Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

    11 Global Autologous Stem Cell Based Therapies Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Autologous Stem Cell Based Therapies Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Autologous Stem Cell Based Therapies Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Autologous Stem Cell Based Therapies Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Autologous Stem Cell Based Therapies Market Competitive Analysis

    • 14.1 Pluristem Therapeutics Inc

      • 14.1.1 Pluristem Therapeutics Inc Company Details

      • 14.1.2 Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Product and Service

    • 14.2 US STEM CELL, INC

      • 14.2.1 US STEM CELL, INC Company Details

      • 14.2.2 US STEM CELL, INC Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 US STEM CELL, INC Autologous Stem Cell Based Therapies Product and Service

    • 14.3 Brainstorm Cell Therapeutics

      • 14.3.1 Brainstorm Cell Therapeutics Company Details

      • 14.3.2 Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Product and Service

    • 14.4 Tigenix

      • 14.4.1 Tigenix Company Details

      • 14.4.2 Tigenix Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Tigenix Autologous Stem Cell Based Therapies Product and Service

    • 14.5 Mesoblast

      • 14.5.1 Mesoblast Company Details

      • 14.5.2 Mesoblast Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Mesoblast Autologous Stem Cell Based Therapies Product and Service

    • 14.6 Regeneus

      • 14.6.1 Regeneus Company Details

      • 14.6.2 Regeneus Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Regeneus Autologous Stem Cell Based Therapies Product and Service

    • 14.7 Med cell Europe

      • 14.7.1 Med cell Europe Company Details

      • 14.7.2 Med cell Europe Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Med cell Europe Autologous Stem Cell Based Therapies Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Autologous Stem Cell Based Therapies

    • Figure Autologous Stem Cell Based Therapies Picture

    • Table Global Autologous Stem Cell Based Therapies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Autologous Stem Cell Based Therapies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Autologous Stem Cell Based Therapies Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Autologous Stem Cell Based Therapies Consumption by Country (2017-2022)

    • Figure United States Autologous Stem Cell Based Therapies Consumption and Growth Rate (2017-2022)

    • Table Europe Autologous Stem Cell Based Therapies Consumption and Growth Rate (2017-2022)

    • Figure China Autologous Stem Cell Based Therapies Consumption and Growth Rate (2017-2022)

    • Figure Japan Autologous Stem Cell Based Therapies Consumption and Growth Rate (2017-2022)

    • Figure India Autologous Stem Cell Based Therapies Consumption and Growth Rate (2017-2022)

    • Figure South Korea Autologous Stem Cell Based Therapies Consumption and Growth Rate (2017-2022)

    • Figure Global Autologous Stem Cell Based Therapies Consumption Forecast by Country (2022-2028)

    • Figure United States Autologous Stem Cell Based Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Autologous Stem Cell Based Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Autologous Stem Cell Based Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Autologous Stem Cell Based Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Autologous Stem Cell Based Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Autologous Stem Cell Based Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Embryonic Stem Cell Consumption and Growth Rate (2017-2022)

    • Figure Global Resident Cardiac Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure Global Umbilical Cord Blood Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure Global Neurodegenerative Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Embryonic Stem Cell Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Resident Cardiac Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Umbilical Cord Blood Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurodegenerative Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Autologous Stem Cell Based Therapies Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Autologous Stem Cell Based Therapies Export by Region (Top 5 Countries) (2017-2028)

    • Table Pluristem Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Product and Service

    • Table US STEM CELL, INC (Foundation Year, Company Profile and etc.)

    • Table US STEM CELL, INC Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table US STEM CELL, INC Autologous Stem Cell Based Therapies Product and Service

    • Table Brainstorm Cell Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Product and Service

    • Table Tigenix (Foundation Year, Company Profile and etc.)

    • Table Tigenix Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tigenix Autologous Stem Cell Based Therapies Product and Service

    • Table Mesoblast (Foundation Year, Company Profile and etc.)

    • Table Mesoblast Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mesoblast Autologous Stem Cell Based Therapies Product and Service

    • Table Regeneus (Foundation Year, Company Profile and etc.)

    • Table Regeneus Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneus Autologous Stem Cell Based Therapies Product and Service

    • Table Med cell Europe (Foundation Year, Company Profile and etc.)

    • Table Med cell Europe Autologous Stem Cell Based Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Med cell Europe Autologous Stem Cell Based Therapies Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US